top of page

NICE draft guidance recommends siponimod for treating secondary progressive multiple sclerosis



NICE has today (15 October 2020) issued draft guidance which now recommends siponimod (also called Mayzent and made by Novartis) for treating secondary progressive multiple sclerosis (MS).




18 views1 comment

1 Kommentar


Debbie Spence
Debbie Spence
30. Dez. 2020

I am a 64 year old female, I was diagnosed of Multiple Sclerosis (MS) in 2008, my symptoms started out with severe fatigue, poor balance, numbness, double vision, heat intolerance and anxiety. I was unable to go back to work, I tried Betaseron for about 6 years. Tried every shot available, all made me sick.In November 2015, I started on Multiple Sclerosis (MS) Herbal formula from Mayaka Natural Clinic, the treatment worked incredibly for my MS condition. I used the Mayaka MS Herbal formula for a total time period of 4 months, it totally reversed my Multiple Sclerosis. I had a total decline of all symptoms including vision problems, numbness and others. Sometimes, i totally forget i ever had MS.…

Gefällt mir
bottom of page